Virtuix to Host Investor Webinar on Growth Plans
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 02 2026
0mins
Should l Buy VTIX?
Source: Newsfilter
- Webinar Announcement: Virtuix will hold a virtual investor webinar on February 4, 2026, at 11:30 AM ET, hosted by Founder and CEO Jan Goetgeluk, to discuss the company's growth plans and dual-market strategy.
- Dual-Market Strategy: The company aims to combine high-volume consumer sales with high-margin defense contracts, leveraging AI-driven 3D reconstruction technology to accelerate product adoption across consumer, enterprise, and defense sectors, thereby enhancing overall market competitiveness.
- Q&A Session: The webinar will feature a question-and-answer session, allowing investors to submit questions in advance via email, which enhances interaction with management and boosts investor confidence.
- Innovation Showcase: Virtuix's
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy VTIX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on VTIX
Wall Street analysts forecast VTIX stock price to rise
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 6.680
Low
Averages
High
Current: 6.680
Low
Averages
High
No data
About VTIX
Virtuix Holdings Inc. is the creator of Omni, the premier brand of omni-directional treadmills that let players walk and run in 360 degrees inside virtual reality (VR) games, digital twins, and other applications. It offers various products that target a variety of industries, namely Omni Pro, Omni Arena, Omni One, and Virtual Terrain Walk (VTW). Omni Pro is its commercial-grade treadmill for enterprise use in arcades, VR centers, corporations, and research institutions. Omni Arena was launched as a turnkey attraction for the out-of-home entertainment industry. The attraction comprises four Omni Pro treadmills for multiplayer gaming and features weekly esports prize contests. Omni One is its most advanced treadmill, supporting full freedom of movement including crouching, kneeling, and jumping. It sells Omni One in three different versions: the complete Omni One system, Omni One Core, and Omni One Enterprise. VTW is its multi-user system for mission planning in the defense industry.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Virtuix Signs Research Agreement with Naval Postgraduate School
- Research Agreement: Virtuix has signed a Cooperative Research and Development Agreement with the Naval Postgraduate School in Monterey, California, marking the company's first formal research collaboration with the U.S. Navy, which is expected to enhance its technology applications in military training and simulation.
- Technology Delivery: Under the agreement, Virtuix will deliver an Omni One system to the Modeling, Virtual Environments, and Simulation Institute at NPS, aimed at assessing the suitability and effectiveness of small-footprint, omni-directional navigation technology for various military tasks.
- Market Potential: This agreement not only provides Virtuix with an opportunity to enter the military market but also lays the groundwork for future product development and market expansion, enhancing the company's competitiveness in related fields.
- Stock Price Reaction: Following the announcement, Virtuix's stock price rose to $6.72 in pre-market trading, reflecting a positive market response to the collaboration agreement and potentially boosting investor confidence in the company's future prospects.
See More
VIRTUIX ENTERS INTO RESEARCH AND DEVELOPMENT PARTNERSHIP WITH U.S. NAVY
- Partnership Announcement: Virtuix has signed a cooperative research and development agreement with the U.S. Navy.
- Focus Areas: The agreement aims to explore advancements in virtual reality and simulation technologies for military applications.
See More
Virtuix Holdings Reports Q3 Financials Amid Direct Listing Plans
- Financial Overview: Virtuix Holdings Inc. reported a Q3 GAAP EPS of -$0.09, indicating challenges in profitability that could undermine investor confidence moving forward.
- Revenue Performance: The company generated $1 million in revenue for Q3, which, while showing some growth compared to the previous year, remains insufficient and highlights the difficulties faced in a competitive market.
- Nine-Month Revenue: Year-to-date, Virtuix Holdings has accumulated $3 million in revenue, suggesting a significant gap from annual revenue targets that may impact future financing capabilities.
- Direct Listing Plans: The company is pursuing a direct listing despite the challenges of low revenue and a risky transition, a strategy that could attract investors interested in emerging markets but also increases market uncertainty.
See More
Virtuix Reports 41% Revenue Growth to $3.0 Million
- Significant Revenue Growth: For the nine months ended December 31, 2025, Virtuix reported net sales of $3.0 million, a 41% increase driven by strong demand for the Omni One system and a successful holiday season, indicating the company's growth potential in the virtual reality market.
- Improved Gross Margin: The gross margin for the nine months improved from -17% in the prior year to 29%, attributed to the price increase of the Omni One system and reduced unit production costs, showcasing the company's success in cost control and pricing strategy.
- Substantial Decrease in Operating Expenses: Operating expenses for the nine months ended December 31, 2025, decreased by 45% to $6.3 million, primarily due to significant reductions in general and administrative expenses, reflecting effective measures in enhancing efficiency and controlling costs.
- International Market Expansion: Through collaboration with Meta, Virtuix has broadened the market reach of Omni One, potentially attracting 6 million active users, further driving the company's growth strategy in the global virtual reality market.
See More
New Show to Air Tonight on Bloomberg Television
- Global Broadcast Expansion: New to The Street's latest episode will air tonight at 6:30 PM EST on Bloomberg Television, extending its reach to the U.S., MENA, and Latin America, thereby enhancing international investor engagement and broadening its audience base.
- Biotech Advancements: BioVie Inc. is advancing a clinical trial for Parkinson's disease with 60 patients enrolled, expecting topline data in May 2026, which could significantly bolster its market position in the biopharmaceutical sector if successful.
- Obstructive Sleep Apnea Solutions: Vivos Therapeutics Inc.'s FDA-cleared non-surgical oral appliance aims to provide a long-term solution for the estimated one billion people affected by OSA globally, with strategic growth initiatives targeting direct-to-patient markets.
- Virtual Reality Market Growth: Virtuix Holdings Inc.'s Omni One platform has reported a 138% year-over-year growth in the gaming and fitness sectors, with production capacity supporting potential annual revenues of up to $100 million, indicating strong demand in both consumer and defense markets.
See More
New Show Airing on Bloomberg Television
- Rich Program Content: Tonight's airing of 'New to The Street' on Bloomberg Television will showcase Virtuix's immersive technology platform, highlighting its rapid growth in consumer and defense markets, which is expected to attract a wide audience.
- International Expansion Update: YY Group will provide updates on its international expansion in Hong Kong, UAE, and Southeast Asia, showcasing AI-enabled workforce automation and strong revenue momentum, indicating its competitiveness in the premium client market.
- Strategic Acquisition Discussion: Roadzen's leadership will discuss its strategic acquisition plans and the scaling of its AI-driven auto insurance and claims ecosystem, demonstrating its innovative capabilities and market potential in the insurance industry.
- Fintech Strategy: Alphaton Capital will outline its fintech-driven investment strategy and capital markets positioning in an interview filmed at the New York Stock Exchange, enhancing its credibility and appeal among global investors.
See More
Virtuix Signs Research Agreement with Naval Postgraduate School
- Research Agreement: Virtuix has signed a Cooperative Research and Development Agreement with the Naval Postgraduate School in Monterey, California, marking the company's first formal research collaboration with the U.S. Navy, which is expected to enhance its technology applications in military training and simulation.
- Technology Delivery: Under the agreement, Virtuix will deliver an Omni One system to the Modeling, Virtual Environments, and Simulation Institute at NPS, aimed at assessing the suitability and effectiveness of small-footprint, omni-directional navigation technology for various military tasks.
- Market Potential: This agreement not only provides Virtuix with an opportunity to enter the military market but also lays the groundwork for future product development and market expansion, enhancing the company's competitiveness in related fields.
- Stock Price Reaction: Following the announcement, Virtuix's stock price rose to $6.72 in pre-market trading, reflecting a positive market response to the collaboration agreement and potentially boosting investor confidence in the company's future prospects.
See More
VIRTUIX ENTERS INTO RESEARCH AND DEVELOPMENT PARTNERSHIP WITH U.S. NAVY
- Partnership Announcement: Virtuix has signed a cooperative research and development agreement with the U.S. Navy.
- Focus Areas: The agreement aims to explore advancements in virtual reality and simulation technologies for military applications.
See More
Virtuix Holdings Reports Q3 Financials Amid Direct Listing Plans
- Financial Overview: Virtuix Holdings Inc. reported a Q3 GAAP EPS of -$0.09, indicating challenges in profitability that could undermine investor confidence moving forward.
- Revenue Performance: The company generated $1 million in revenue for Q3, which, while showing some growth compared to the previous year, remains insufficient and highlights the difficulties faced in a competitive market.
- Nine-Month Revenue: Year-to-date, Virtuix Holdings has accumulated $3 million in revenue, suggesting a significant gap from annual revenue targets that may impact future financing capabilities.
- Direct Listing Plans: The company is pursuing a direct listing despite the challenges of low revenue and a risky transition, a strategy that could attract investors interested in emerging markets but also increases market uncertainty.
See More
Virtuix Reports 41% Revenue Growth to $3.0 Million
- Significant Revenue Growth: For the nine months ended December 31, 2025, Virtuix reported net sales of $3.0 million, a 41% increase driven by strong demand for the Omni One system and a successful holiday season, indicating the company's growth potential in the virtual reality market.
- Improved Gross Margin: The gross margin for the nine months improved from -17% in the prior year to 29%, attributed to the price increase of the Omni One system and reduced unit production costs, showcasing the company's success in cost control and pricing strategy.
- Substantial Decrease in Operating Expenses: Operating expenses for the nine months ended December 31, 2025, decreased by 45% to $6.3 million, primarily due to significant reductions in general and administrative expenses, reflecting effective measures in enhancing efficiency and controlling costs.
- International Market Expansion: Through collaboration with Meta, Virtuix has broadened the market reach of Omni One, potentially attracting 6 million active users, further driving the company's growth strategy in the global virtual reality market.
See More
New Show to Air Tonight on Bloomberg Television
- Global Broadcast Expansion: New to The Street's latest episode will air tonight at 6:30 PM EST on Bloomberg Television, extending its reach to the U.S., MENA, and Latin America, thereby enhancing international investor engagement and broadening its audience base.
- Biotech Advancements: BioVie Inc. is advancing a clinical trial for Parkinson's disease with 60 patients enrolled, expecting topline data in May 2026, which could significantly bolster its market position in the biopharmaceutical sector if successful.
- Obstructive Sleep Apnea Solutions: Vivos Therapeutics Inc.'s FDA-cleared non-surgical oral appliance aims to provide a long-term solution for the estimated one billion people affected by OSA globally, with strategic growth initiatives targeting direct-to-patient markets.
- Virtual Reality Market Growth: Virtuix Holdings Inc.'s Omni One platform has reported a 138% year-over-year growth in the gaming and fitness sectors, with production capacity supporting potential annual revenues of up to $100 million, indicating strong demand in both consumer and defense markets.
See More
New Show Airing on Bloomberg Television
- Rich Program Content: Tonight's airing of 'New to The Street' on Bloomberg Television will showcase Virtuix's immersive technology platform, highlighting its rapid growth in consumer and defense markets, which is expected to attract a wide audience.
- International Expansion Update: YY Group will provide updates on its international expansion in Hong Kong, UAE, and Southeast Asia, showcasing AI-enabled workforce automation and strong revenue momentum, indicating its competitiveness in the premium client market.
- Strategic Acquisition Discussion: Roadzen's leadership will discuss its strategic acquisition plans and the scaling of its AI-driven auto insurance and claims ecosystem, demonstrating its innovative capabilities and market potential in the insurance industry.
- Fintech Strategy: Alphaton Capital will outline its fintech-driven investment strategy and capital markets positioning in an interview filmed at the New York Stock Exchange, enhancing its credibility and appeal among global investors.
See More
